<ARTICLE> 5 <LEGEND> This schedule contains summary financial information extracted from the BioCryst Pharmaceuticals, Inc. Financial Statements, and is qualified in its entirety by reference to such financial statements. </LEGEND> <PERIOD-TYPE> YEAR 3-MOS <FISCAL-YEAR-END> DEC-31-1995 DEC-31-1996 <PERIOD-START> JAN-01-1995 JAN-01-1996 <PERIOD-END> DEC-31-1995 JUN-30-1996 <CASH> 6,134,968 6,272,730 <SECURITIES> 5,279,076 11,540,354 <RECEIVABLES> 0 0 <ALLOWANCES> 0 0 <INVENTORY> 0 0 <CURRENT-ASSETS> 11,693,430 18,438,773 <PP&E> 3,065,587 3,195,983 <DEPRECIATION> 1,702,804 1,967,437 <TOTAL-ASSETS> 13,056,213 19,667,319 <CURRENT-LIABILITIES> 1,129,304 1,416,022 <BONDS> 0 0 <PREFERRED-MANDATORY> 0 0 <PREFERRED> 0 0 <COMMON> 95,043 106,234 <OTHER-SE> 11,231,455 17,696,951 <TOTAL-LIABILITY-AND-EQUITY> 13,056,213 19,667,319 <SALES> 0 0 <TOTAL-REVENUES> 222,329 1,521,279 <CGS> 0 0 <TOTAL-COSTS> 0 0 <OTHER-EXPENSES> 0 0 <LOSS-PROVISION> 0 0 <INTEREST-EXPENSE> 144,115 55,629 <INCOME-PRETAX> (8,576,264) (3,123,518) <INCOME-TAX> 0 0 <INCOME-CONTINUING> 0 0 <DISCONTINUED> 0 0 <EXTRAORDINARY> 0 0 <CHANGES> 0 0 <NET-INCOME> (8,576,264) (3,123,518) <EPS-PRIMARY> (0.96) (0.31) <EPS-DILUTED> (0.96) (0.31)